(S (NP-SBJ-59 (NP (ADJP Interleukin/NN 6-induced/JJ) differentiation/NN) (PP of/IN (NP a/DT human/JJ B/NN cell/NN line/NN)) (PP into/IN (NP IgM-secreting/JJ plasma/NN cells/NNS))) (VP is/VBZ (VP mediated/VBN (NP *-59/-NONE-) (PP by/IN (NP-LGS c-fos/NN)))) ./.)
(S (NP-SBJ-60 (NP The/DT role/NN) (PP of/IN (NP the/DT protooncogene/NN c-fos/NN)) (PP in/IN (NP (ADJP interleukin/NN -LRB-/-LRB- IL/NN -RRB-/-RRB- 6-induced/JJ) B/NN cell/NN differentiation/NN))) (VP was/VBD (VP assessed/VBN (NP *-60/-NONE-))) ./.)
(S (NP-SBJ (NP Treatment/NN) (PP of/IN (NP SKW/NN 6.4/CD cells/NNS)) (PP with/IN (NP IL/NN 6/CD))) (VP induced/VBD (NP (NP a/DT (ADJP-COOD (ADJP transient/JJ) and/CC (ADJP early/JJ)) stimulation/NN) (PP of/IN (NP c-fos/NN sense/NN mRNA/NN expression/NN)))) ./.)
(S (NP-SBJ The/DT effect/NN) (VP-COOD (VP appeared/VBD (PP-TMP within/IN (NP 30/CD min/NN))) and/CC (VP returned/VBD (PP to/TO (NP basal/JJ levels/NNS)) (PP-TMP after/IN (NP 2/CD h/NN)))) ./.)
(S-COOD (S (NP-SBJ (NP The/DT addition/NN) (PP of/IN (NP antisense/JJ oligonucleotides/NNS)) (PP to/TO (NP c-fos/NN))) (ADVP significantly/RB) (VP inhibited/VBD (NP (ADJP IL/NN 6-induced/JJ) IgM/NN production/NN) (PP by/IN (NP SKW/NN 6.4/CD cells/NNS)) (PRN -LRB-/-LRB- (S (NP-SBJ p/NN) (NP-PRD (QP less/JJR than/IN 0.001/CD))) -RRB-/-RRB-))) ,/, whereas/IN (S (NP-SBJ control/NN oligonucleotides/NNS) (VP had/VBD (NP no/DT inhibitory/JJ effect/NN))) ./.)
(S (NP-SBJ These/DT results/NNS) (VP indicate/VBP (SBAR that/IN (S (NP-SBJ-61 (NP activation/NN) (PP of/IN (NP c-fos/NN))) (VP is/VBZ (VP involved/VBN (NP *-61/-NONE-) (PP in/IN (NP (NP (ADJP IL/NN 6-induced/JJ) differentiation/NN) (PP of/IN (NP SKW/NN 6.4/CD cells/NNS)) (PP into/IN (NP IgM-secreting/JJ cells/NNS))))))))) ./.)
